Literature DB >> 29773162

Psychopharmacology and Cardiovascular Disease.

Ileana L Piña1, Katherine E Di Palo2, Hector O Ventura3.   

Abstract

This review discusses common mental health disorders and their associations with cardiovascular disease risks. Commonly found mental health disorders include depression, anxiety, and personality types. The link between depression and cardiovascular disease mortality has been established. Depression is also common in patients with heart failure. In addition to discussing psychological disorders, a review of psychotropic drugs is also included. Drugs are described for therapy for depression and anxiety, as well as associations with cardiovascular drug-drug interactions. Drug-drug interactions are more common and potentially dangerous in elderly patients, in whom the conditions often coexist. The most common drug-drug interactions involve the P450 system of enzymes.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  drug-drug interactions; psychiatric disorders; psychopharmacology

Mesh:

Substances:

Year:  2018        PMID: 29773162     DOI: 10.1016/j.jacc.2018.03.458

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

Review 1.  Depression, Anxiety, and Cognitive Impairment : Comorbid Mental Health Disorders in Heart Failure.

Authors:  Christiane E Angermann; Georg Ertl
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 2.  Improving Provider Adherence to Guideline Recommendations in Heart Failure.

Authors:  Katherine E Di Palo; Ileana L Piña; Hector O Ventura
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 3.  Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Manish K Jha; Arman Qamar; Muthiah Vaduganathan; Dennis S Charney; James W Murrough
Journal:  J Am Coll Cardiol       Date:  2019-04-16       Impact factor: 24.094

4.  Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years.

Authors:  Sylvie Mesrine; Gaëlle Gusto; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Agnès Fournier
Journal:  Eur J Clin Pharmacol       Date:  2018-07-04       Impact factor: 2.953

5.  Cardiac and behavioral effects of social isolation and experimental manipulation of autonomic balance.

Authors:  Angela J Grippo; Melissa-Ann L Scotti; Joshua Wardwell; Neal McNeal; Suzanne L Bates; Danielle L Chandler; Elliott Ihm; Nalini Jadia
Journal:  Auton Neurosci       Date:  2018-08-15       Impact factor: 3.145

Review 6.  Identifying Stage D Heart Failure: Data From the Most Recent Registries.

Authors:  Thomas M Cascino; Keith D Aaronson; Garrick C Stewart
Journal:  Curr Heart Fail Rep       Date:  2019-10

Review 7.  Autonomic Neural Circuit and Intervention for Comorbidity Anxiety and Cardiovascular Disease.

Authors:  Xuanzhao Chen; Li Xu; Zeyan Li
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

8.  Major Cardiac-Psychiatric Drug-Drug Interactions: a Systematic Review of the Consistency of Drug Databases.

Authors:  João Mauricio Castaldelli-Maia; Caio Hofmann; Antonio Carlos Palandri Chagas; Alvaro Sosa Liprandi; Alejandro Alcocer; Laura H Andrade; Andreas Wielgosz
Journal:  Cardiovasc Drugs Ther       Date:  2021-06       Impact factor: 3.727

9.  Relationship of Psychological Characteristics to Daily Life Ischemia: An Analysis From the National Heart, Lung, and Blood Institute Psychophysiological Investigations in Myocardial Ischemia.

Authors:  Osama Dasa; Ahmed N Mahmoud; Peter G Kaufmann; Mark Ketterer; Kathleen C Light; James Raczynski; David S Sheps; Peter H Stone; Eileen Handberg; Carl J Pepine
Journal:  Psychosom Med       Date:  2022-04-01       Impact factor: 4.312

10.  Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients.

Authors:  HongYan Wei; JunYuan Gu; XueYao Jiang; Nan Deng; Jing Wu; LianHong Zou; YiMin Zhu; BoYu Tan
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.